May 21, 2002
OPCAB, Image-Guidance and Other Innovations Pushing Surgical Limits
FOOTHILL RANCH, Calif., May 21 /PRNewswire/ -- Innovation in surgical technologies is dramatically lowering invasiveness and increasing surgical precision, from "beating heart" coronary artery bypass to image-guided surgery. "The advancement of surgery is a story of innovation. Traditional surgeries are being altered, creating new niches for specialized medical devices," said Patrick J. Driscoll, Publisher of "MedMarkets", in which the surgical technologies are covered in the May 2002 issue.
In "beating heart" or off-pump coronary artery bypass (OPCAB), in which cardiac surgeons avoid the use of cardiopulmonary bypass, innovations are enabling the procedure to account for an increasing share of bypass caseload. "Already, about 25% of all coronary bypass procedures are performed off-pump," said Driscoll. "However," he continued, "that number will grow at an impressive rate." Leading and upcoming companies involved in the OPCAB device market include: Abbey Surgical, A-Med Systems, CardioMed, ESTECH, Genzyme Biosurgery, Guidant, Medcanica, MediVas OPCAB, and Medtronic.
On a second front, developments in image-guided surgery are enabling surgeons to perform complex, minimally invasive procedures. "In some cases," says Driscoll, "these systems are providing treatment where previously none was possible, such as in many neuro applications. In others, great leaps in outcomes are made possible by more precise surgery." Image-guided systems developed for applications in spine surgery hold the greatest promise for near-term growth. Companies involved in the market for neurosurgical IGS equipment include: Medtronic Sofamor Danek, BrainLAB, Radionics, Visualization Technology, Accuray, CBYON, and Odin Medical Technologies.
The May 2002 issue of "MedMarkets" introduces a new regular feature called "Leading Clinical Edge," providing insights into new clinical practice that may well create new medtech markets or new challenges for existing ones. Another addition to coverage is "Startups", listing newly formed medtech companies that may create, penetrate or displace multimillion dollar markets in the not-too-distant future.
"MedMarkets", published by MedMarket Diligence, analyzes the market and clinical practice implications of developments in medical technology -- medical devices, equipment and supplies as well as biomaterials, biotech, pharmaceutical, e-health and others. In addition to "MedMarkets," the company publishes dedicated market/technology reports, and is developing other information solutions. For more information on "MedMarkets" or MedMarket Diligence, LLC, contact Patrick Driscoll at (949) 859-3401, e-mail, or visit the Web site at http://www.mediligence.com to view a sample issue in its entirety.